Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Heritage Mining's Contact Bay: Two Large Ni-Cu-PGE Mafic-Ultramafic Intrusives (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Zymeworks Inc ZYME

Healthcare Biotechnology
Zymeworks Inc. is a global biotechnology company. The Company is engaged in the discovery, development, and commercialization of multifunctional biotherapeutics to treat cancer and other serious diseases. Its lead product candidate, zanidatamab, is a bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Its second product candidate... see more

Bullboard (NDAQ:ZYME)

View:
1 2 3 Next
User Avatar Image
(1301)
•••
  • Possibleidiot01X
Post by Possibleidiot01on May 16, 2023 6:50am

Paradigm - cantechletter.com

Zymeworks gets a target trim from Paradigm Paradigm Capital analyst Scott McAuley lowered his target a notch on biopharma developer Zymeworks (Zymeworks Stock Quote, Charts, News, Analysts ...more  
82
Post by Gringottson Mar 08, 2023 8:51am

As some have noted..

Yesterday's quarterly and yearly results, smashed earnings and revenue estimates.  ZYME is ridiculously undervalued.  Lets see if the market finally wakes up to the very positive ZYME ...more  
91
Comment by 7Twiggyon Nov 15, 2022 11:35am

RE:ZYME contiuing it's trend up

And one she goes this morning. Over 8.70 and shows no signs of slowing down.
49
Post by 7Twiggyon Nov 10, 2022 2:37pm

ZYME contiuing it's trend up

Continues it's trend up.  Moved through 8.00 and showing a lot of strength these past two weeks.  Some good posts of Yahoo finance and Stocktwits.  So far this board dead. Short ...more  
68
Post by 7Twiggyon Aug 12, 2022 4:06pm

I think we are headed into double digits sooner than later.

Another great day for Zymeworks.  Another 6 percent up.  Higher highs and lower lows the name of the game. I think we are headed into double digits sooner than later.  This board still ...more  
133
Post by 7Twiggyon Aug 11, 2022 7:46pm

Looks to me like Zyme is on its way back.

Looks to me like Zyme is on its way back. Continue to add on positive moves up. Should see continued move up as we head to those September conferences. Another great day. Added again yesterday and am ...more  
109
Comment by Gringottson Aug 06, 2022 9:37pm

RE:News Release?

Sorry...I'm wrong. Galbraith is still in his position as CEO. Darn! Form 8-K (sec.gov)
74
Post by Gringottson Aug 06, 2022 8:48pm

News Release?

The market needs an official press release to prove this useless CEO has been turfed. I hope ZYME can soon recover from this nightmare CEO. 
134
Comment by Gringottson Aug 06, 2022 7:45pm

RE:Could this be the start of a move up?

I, as sure as h.ell, hope so! Galbraith is a nightmare. I hope this is true. 
53
Post by 7Twiggyon Aug 05, 2022 7:19pm

And more

By Albert Van Santvoort | May 6, 2019, 11:55pm   Neil Klompas, CFO, Zymeworks | Chung Chow When ...more  
104
Post by 7Twiggyon Aug 05, 2022 7:15pm

Bio new pres

Neil Klompas EVP, Business Operations & CFO Join to edit Mr. Klompas joined Zymeworks in March 2007 and currently serves as the Executive Vice President, Business Operations and ...more  
81
Post by 7Twiggyon Aug 05, 2022 7:03pm

Could this be the start of a move up?

8-K Emp Changes Reg FD – Zymeworks Inc. (0001403752) August 04  Posted on August 5, 2022   ByNews Desk ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS ...more  
97
Post by 7Twiggyon Jun 14, 2022 4:04pm

Nice move today

Nice move today. I added.  Looks like a good buy. Still doing DD
78
Post by Gringottson May 07, 2022 2:06pm

Update on ABC Offer for ZYME

By Jonathan Braude May 05, 2022 09:24 AM Dubai-based private equity investor All Blue Capital Ltd. is prepared to go hostile with its $733 million takeover offer for Canadian drug developer  ...more  
288
1 2 3 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >